{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:31:29Z","timestamp":1776817889524,"version":"3.51.2"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["1-0025"],"award-info":[{"award-number":["1-0025"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HD-087351"],"award-info":[{"award-number":["HD-087351"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-130253"],"award-info":[{"award-number":["HL-130253"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-138426"],"award-info":[{"award-number":["HL-138426"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.yjmcc.2023.03.013","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T03:40:31Z","timestamp":1680061231000},"page":"2-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Reprogramming of cardiac cell fate as a therapeutic strategy for ischemic heart disease"],"prefix":"10.1016","volume":"179","author":[{"given":"Glynnis A.","family":"Garry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric N.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.013_bb0005","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke Statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.yjmcc.2023.03.013_bb0010","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.03.013_bb0015","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamacardio.2020.2696","article-title":"Trends in US heart transplant waitlist activity and volume during the coronavirus disease 2019 (COVID-19) pandemic","volume":"5","author":"DeFilippis","year":"2020","journal-title":"JAMA Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.013_bb0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(99)00630-0","article-title":"Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling","volume":"35","author":"Cohn","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2023.03.013_bb0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.013_bb0030","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"issue":"7400","key":"10.1016\/j.yjmcc.2023.03.013_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"issue":"7400","key":"10.1016\/j.yjmcc.2023.03.013_bb0040","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.yjmcc.2023.03.013_bb0045","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate","volume":"110","author":"Nam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.03.013_bb0050","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.116.024692","article-title":"Chemical enhancement of in vitro and in vivo direct cardiac reprogramming","volume":"135","author":"Mohamed","year":"2017","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.yjmcc.2023.03.013_bb0055","doi-asserted-by":"crossref","first-page":"11864","DOI":"10.1073\/pnas.1516237112","article-title":"Akt1\/protein kinase B enhances transcriptional reprogramming of fibroblasts to functional cardiomyocytes","volume":"112","author":"Zhou","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.013_bb0060","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41467-019-08626-y","article-title":"Role of cyclooxygenase-2-mediated prostaglandin E2-prostaglandin E receptor 4 signaling in cardiac reprogramming","volume":"10","author":"Muraoka","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0065","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0070","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/ncomms9243","article-title":"High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling","volume":"6","author":"Zhao","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.013_bb0075","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.stemcr.2017.01.025","article-title":"Notch inhibition enhances cardiac reprogramming by increasing MEF2C transcriptional activity","volume":"8","author":"Abad","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.03.013_bb0080","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCRESAHA.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ. Res."},{"issue":"14","key":"10.1016\/j.yjmcc.2023.03.013_bb0090","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/embj.201387605","article-title":"MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures","volume":"33","author":"Muraoka","year":"2014","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.013_bb0095","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41556-021-00668-z","article-title":"The histone reader PHF7 cooperates with the SWI\/SNF complex at cardiac super enhancers to promote direct reprogramming","volume":"23","author":"Garry","year":"2021","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.yjmcc.2023.03.013_bb0105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2016.02.003","article-title":"Bmi1 is a key epigenetic barrier to direct cardiac reprogramming","volume":"18","author":"Zhou","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.013_bb0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.stem.2019.03.022","article-title":"Cardiac reprogramming factors synergistically activate genome-wide cardiogenic stage-specific enhancers","volume":"25","author":"Hashimoto","year":"2019","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.013_bb0115","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.stem.2019.05.020","article-title":"Single-cell transcriptomic analyses of cell fate transitions during human cardiac reprogramming","volume":"25","author":"Zhou","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2021.09.002","article-title":"Delineating chromatin accessibility re-patterning at single cell level during early stage of direct cardiac reprogramming","volume":"162","author":"Wang","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.013_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081805","article-title":"Single-construct Polycistronic doxycycline-inducible vectors improve direct cardiac reprogramming and can be used to identify the critical timing of transgene expression","volume":"18","author":"Umei","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.013_bb0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/cvr\/cvt167","article-title":"Accelerated direct reprogramming of fibroblasts into cardiomyocyte-like cells with the MyoD transactivation domain","volume":"100","author":"Hirai","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.yjmcc.2023.03.013_bb0135","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/CIRCRESAHA.116.308741","article-title":"Demethylation of H3K27 is essential for the induction of direct cardiac reprogramming by miR combo","volume":"120","author":"Dal-Pra","year":"2017","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.yjmcc.2023.03.013_bb0140","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/stem.2833","article-title":"Cardiomyocyte maturation requires TLR3 activated nuclear factor kappa B","volume":"36","author":"Hodgkinson","year":"2018","journal-title":"Stem Cells"},{"issue":"20","key":"10.1016\/j.yjmcc.2023.03.013_bb0145","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.122.059713","article-title":"TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming","volume":"146","author":"Tang","year":"2022","journal-title":"Circulation"},{"issue":"6562","key":"10.1016\/j.yjmcc.2023.03.013_bb0150","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1126\/science.abg5159","article-title":"Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice","volume":"373","author":"Chen","year":"2021","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.yjmcc.2023.03.013_bb0155","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41556-022-00901-3","article-title":"ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage","volume":"24","author":"Gong","year":"2022","journal-title":"Nat. Cell Biol."},{"issue":"11","key":"10.1016\/j.yjmcc.2023.03.013_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2107339119","article-title":"A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7284","key":"10.1016\/j.yjmcc.2023.03.013_bb0165","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2023.03.013_bb0170","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.stemcr.2014.05.020","article-title":"Generation of induced neuronal cells by the single reprogramming factor ASCL1","volume":"3","author":"Chanda","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"16","key":"10.1016\/j.yjmcc.2023.03.013_bb0175","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1101\/gad.16875711","article-title":"Context-specific alpha- to-beta-cell reprogramming by forced Pdx1 expression","volume":"25","author":"Yang","year":"2011","journal-title":"Genes Dev."},{"issue":"24","key":"10.1016\/j.yjmcc.2023.03.013_bb0180","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1101\/gad.253443.114","article-title":"Pioneer transcription factors in cell reprogramming","volume":"28","author":"Iwafuchi-Doi","year":"2014","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.yjmcc.2023.03.013_bb0185","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.stem.2022.09.006","article-title":"Cross-lineage potential of Ascl1 uncovered by comparing diverse reprogramming regulatomes","volume":"29","author":"Wang","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"24","key":"10.1016\/j.yjmcc.2023.03.013_bb0190","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022659","article-title":"Hippo pathway effector Tead1 induces cardiac fibroblast to cardiomyocyte reprogramming","volume":"10","author":"Singh","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0195","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","article-title":"Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction","volume":"147","author":"Tani","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0200","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bbrc.2021.04.121","article-title":"Direct reprogramming with Sendai virus vectors repaired infarct hearts at the chronic stage","volume":"560","author":"Isomi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.013_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stem.2017.11.010","article-title":"Direct in vivo reprogramming with Sendai virus vectors improves cardiac function after myocardial infarction","volume":"22","author":"Miyamoto","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2023.03.013_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1367","article-title":"Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease","volume":"9","author":"Hadas","year":"2017","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0215","article-title":"Delivery of modified mRNA in a myocardial infarction mouse model","volume":"160","author":"Kaur","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0220","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2201422","article-title":"Genetically modified porcine-to-human cardiac xenotransplantation","volume":"387","author":"Griffith","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2023.03.013_bb0225","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.122.059191","article-title":"Cardiac xenotransplantation: clinical impact of science and discovery","volume":"146","author":"Garry","year":"2022","journal-title":"Circulation."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282823000585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:37:34Z","timestamp":1758314254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282823000585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":43,"alternative-id":["S0022282823000585"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.013","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reprogramming of cardiac cell fate as a therapeutic strategy for ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2023.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}